| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VAXX | Class A Common Stock | Sale | -$2.35K | -1.25K | -0.06% | $1.88 | 2.06M | Sep 6, 2023 | Held by COVAXX PML SPV 1 LP | F1, F2, F7 |
| transaction | VAXX | Class A Common Stock | Sale | -$9.99K | -5.31K | -0.06% | $1.88 | 8.76M | Sep 6, 2023 | Direct | F1, F3, F7 |
| transaction | VAXX | Class A Common Stock | Sale | -$954 | -507 | -0.06% | $1.88 | 836K | Sep 6, 2023 | Held by COVAXX PML SPV 2 LP | F1, F4, F7 |
| transaction | VAXX | Class A Common Stock | Sale | -$1.68K | -892 | -0.06% | $1.88 | 1.47M | Sep 6, 2023 | Held by COVAXX PML SPV 3 LP | F1, F5, F7 |
| transaction | VAXX | Class A Common Stock | Sale | -$4.12K | -2.19K | -0.06% | $1.88 | 3.61M | Sep 6, 2023 | Held by Prime Movers Growth Fund 1 LP | F1, F6, F7 |
| transaction | VAXX | Class A Common Stock | Sale | -$8.55K | -4.79K | -0.23% | $1.79 | 2.06M | Sep 7, 2023 | Held by COVAXX PML SPV 1 LP | F2, F7, F8 |
| transaction | VAXX | Class A Common Stock | Sale | -$36.3K | -20.3K | -0.23% | $1.79 | 8.74M | Sep 7, 2023 | Direct | F3, F7, F8 |
| transaction | VAXX | Class A Common Stock | Sale | -$3.47K | -1.94K | -0.23% | $1.79 | 834K | Sep 7, 2023 | Held by COVAXX PML SPV 2 LP | F4, F7, F8 |
| transaction | VAXX | Class A common stock | Sale | -$6.1K | -3.41K | -0.23% | $1.79 | 1.47M | Sep 7, 2023 | Held by COVAXX PML SPV 3 LP | F5, F7, F8 |
| transaction | VAXX | Class A common stock | Sale | -$15K | -8.38K | -0.23% | $1.79 | 3.6M | Sep 7, 2023 | Held by Prime Movers Growth Fund 1 LP | F6, F7, F8 |
| transaction | VAXX | Class A common stock | Sale | -$9.87K | -5.91K | -0.29% | $1.67 | 2.05M | Sep 8, 2023 | Held by COVAXX PML SPV 1 LP | F2, F7, F9 |
| transaction | VAXX | Class A common stock | Sale | -$41.9K | -25.1K | -0.29% | $1.67 | 8.71M | Sep 8, 2023 | Direct | F3, F7, F9 |
| transaction | VAXX | Class A Common Stock | Sale | -$4K | -2.4K | -0.29% | $1.67 | 832K | Sep 8, 2023 | Held by COVAXX PML SPV 2 LP | F4, F7, F9 |
| transaction | VAXX | Class A common stock | Sale | -$7.04K | -4.22K | -0.29% | $1.67 | 1.46M | Sep 8, 2023 | Held by COVAXX PML SPV 3 LP | F5, F7, F9 |
| transaction | VAXX | Class A common stock | Sale | -$17.3K | -10.3K | -0.29% | $1.67 | 3.59M | Sep 8, 2023 | Held by Prime Movers Growth Fund 1 LP | F6, F7, F9 |
| Id | Content |
|---|---|
| F1 | The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
| F2 | Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. |
| F3 | Held by PML. PML GP I is the general partner of PML. |
| F4 | Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. |
| F5 | Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. |
| F6 | Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. |
| F7 | Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| F8 | The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
| F9 | The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |